Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,347 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial.
Roncalli J, Roubille F, Meyer N, Pompilio G, Leroux L, Henon P, Trebuchet G, Criquet A, de Kalbermatten M, Saloux E, Manrique A, Marie PY, Bhatt DL, Solomon SD, Montalescot G, Newby DE, Zannad F; EXCELLENT Trial Investigators. Roncalli J, et al. Among authors: meyer n. ESC Heart Fail. 2024 Dec 15. doi: 10.1002/ehf2.15124. Online ahead of print. ESC Heart Fail. 2024. PMID: 39676512 Free article.
The TOTEM RRMS (Testosterone Treatment on neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis) trial: study protocol for a randomized, double-blind, placebo-controlled trial.
Metzger-Peter K, Kremer LD, Edan G, Loureiro De Sousa P, Lamy J, Bagnard D, Mensah-Nyagan AG, Tricard T, Mathey G, Debouverie M, Berger E, Kerbrat A, Meyer N, De Seze J, Collongues N. Metzger-Peter K, et al. Among authors: meyer n. Trials. 2020 Jun 29;21(1):591. doi: 10.1186/s13063-020-04517-6. Trials. 2020. PMID: 32600454 Free PMC article.
SARS-CoV-2 ORF8 drives osteoclastogenesis in preexisting immune-mediated inflammatory diseases.
Melano I, Azamor T, Caetano CC, Meyer NM, Onwubueke C, Visperas A, Familiar-Macedo D, Salem GM, Soos BL, Calabrese CM, Choi YJ, Chen S, Choi Y, Wu X, Vasconcelos Z, Comhair SA, Nielsen-Saines K, Calabrese LH, Husni ME, Jung JU, Piuzzi NS, Foo SS, Chen W. Melano I, et al. Among authors: meyer nm. JCI Insight. 2024 Dec 20;9(24):e178820. doi: 10.1172/jci.insight.178820. JCI Insight. 2024. PMID: 39704167 Free PMC article.
Effectiveness, safety and reasons for discontinuation of sonidegib for patients with locally advanced basal cell carcinoma: A real-word evidence analysis from the French national registry CARADERM.
Basset-Seguin N, Djermane M, Herms F, Dalac S, Dereure O, Beylot-Barry M, Amini-Adle M, Minart B, Granel-Brocard F, Meyer N, Jouary T, Dreno B, Mortier L; Caraderm investigators. Basset-Seguin N, et al. Among authors: meyer n. J Eur Acad Dermatol Venereol. 2024 Dec 16. doi: 10.1111/jdv.20496. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 39676714 No abstract available.
In the Spotlight-Established Researcher.
Meyer N. Meyer N. J Exp Zool B Mol Dev Evol. 2025 Jan;344(1):5-6. doi: 10.1002/jez.b.23281. Epub 2024 Nov 28. J Exp Zool B Mol Dev Evol. 2025. PMID: 39610017 No abstract available.
International multi-cohort analysis identifies novel framework for quantifying immune dysregulation in critical illness: results of the SUBSPACE consortium.
Moore AR, Zheng H, Ganesan A, Hasin-Brumshtein Y, Maddali MV, Levitt JE, van der Poll T, Scicluna BP, Giamarellos-Bourboulis EJ, Kotsaki A, Martin-Loeches I, Garduno A, Rothman RE, Sevransky J, Wright DW, Atreya MR, Moldawer LL, Efron PA, Marcela K, Karvunidis T, Giannini HM, Meyer NJ, Sweeney TE, Rogers AJ, Khatri P. Moore AR, et al. Among authors: meyer nj. bioRxiv [Preprint]. 2024 Nov 15:2024.11.12.623298. doi: 10.1101/2024.11.12.623298. bioRxiv. 2024. PMID: 39605502 Free PMC article. Preprint.
1,347 results